Wed, Jul 23, 2014, 7:44 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Neurocrine Biosciences Inc. Message Board

  • coldpizza22 coldpizza22 Apr 30, 2013 8:47 PM Flag

    From post on Investor Village NBIX board

    what the H is this?????????????

    comments that Endometriosis P3 Violet Petal is recruiting more patients??????

    if that is true than we won't see P3 top Line data untill late 2014
    The trial is 6 months of treatment 6 to 12 months of follow up.

    I really hope this gets clarified on Thursday or NBIX going to trade back to single digits.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • From todays Needham Presentation and their New corporate slides that are on thier Web site.

      So now NBIX management talking sometime in 2014 for top Line violet petal study read out vs the more anticipated 1H/14. So I would say Q4/14 is the best we are going to get and knowing this management team and their History of meeting dead lines think early 2015.

      The stock continues its slide this AM

 
NBIX
13.71+0.16(+1.18%)Jul 23 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.